Onco-Innovations Ratios and Metrics

Market cap in millions CAD. Fiscal year is May - April.

Millions CAD. Fiscal year is May - Apr.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 6, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023
Market Capitalization	37	76	-	-
Enterprise Value	36	76	-	-
Last Close Price	0.65	1.50	-	-
PS Ratio	241.97	1164.95	-	-
PB Ratio	20.69	42.13	-	-
P/TBV Ratio	20.69	42.13	-	-
EV/Sales Ratio	234.94	1158.58	-	-
Net Debt / Equity Ratio	-0.60	-0.62	-1.40	-1.00
Asset Turnover	-	0.05	-	-
Quick Ratio	2.32	2.94	3.47	-
Current Ratio	4.40	5.41	3.47	-
Return on Equity (ROE)	-	-799.79%	-233.40%	-
Return on Assets (ROA)	-	-144.12%	-105.54%	-
Return on Capital Employed (ROCE)	-371.80%	-170.10%	-123.50%	-1.30%
Earnings Yield	-38.10%	-11.17%	-	-
Buyback Yield / Dilution	-	-905.82%	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.